Ołów i jego związki nieorganiczne (w przeliczeniu na Pb)

• Autorzy: Jakubowski M.

Warianty tytułu

EN

Lead and its inorganic compounds

• Języki publikacji: PL

Słowa kluczowe

PL

ołów; właściwości fizykochemiczne; działanie toksyczne; toksykokinetyka; ołów i jego związki nieorganiczne

EN

lead; physicochemical properties; toxic effects; toxicokinetics; lead and its inorganic compounds

• Wydawca: Centralny Instytut Ochrony Pracy - Państwowy Instytut Badawczy
• Czasopismo: Podstawy i Metody Oceny Środowiska Pracy
• Rocznik: 1999
• Tom: Nr 21
• Strony: 115--168
• Opis fizyczny: Bibliogr. 177 poz., rys., tab.

Twórcy

autor

Jakubowski M.

• Instytut Medycyny Pracy im. prof. dr. med. Jerzego Nofera 90-950 Łódź ul. św. Teresy 8

Bibliografia

• 1. ACGIH. Threshold Limit Values for Chemical Substances ans Physical Agents and Biological Exposure Indices, Cincinnati 1996.
• 2. Air quality criteria for lead. Research Triangle Park, NC. U.S. Environmental Protection Agency. Office of Research and Development, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office. EPA 600/8-83-028F, 1986.
• 3. Alessio L., Foa V.: Lead. W: Human biological monitoring of industrial chemicals series. Office for Official Publications of the European Communities. Luxembourg 1983, s. 105-132.
• 4. Al Hakkak Z.S.H. i in.: Chromosome aberration in workers at a storage battery plant in Iraq. Mut. Res. 1986, 171,53-60.
• 5. Araki S. i in.: Recovery of slowed nerve conduction velocity in lead-exposed workers. Int. Arch. Occup. Environ. Health 1980,46, 151-157.
• 6. Arnvig E., Grandjean P., Beckmann J.: Neurotoxic effecta of heavy lead exposure determined with psychological tests. Toxicol. Lett. 1980, 5, 399-404.
• 7. Assennato G., Baser M., Molinini R.: Sperm count suppression without endocrine dysfunction in lead exposed men. Arch. Environ. Health 1987, 42, 124-127.
• 8. Awad El Karim M.A. i in.: Effects of exposure to lead among lead acid battery factory workers in Sudan. Arch. Environ. Health 1986,41, 261-265.
• 9. Azar A., Trochimowicz H.J., Maxfield M.E.: Reviev of lead studies in animals carried out at Haskell Laboratory: Two year feeding study and response to hemmorage study. [W]: Environmental health aspects of lead. Proceedings, International Symposium, October 1972 Amsterdam, Luxembourg CEC 1973, 199-210.
• 10. Baghurst P.A. i in.: The port pirie cohort study. Lead effects on pregnancy outcome and early childhood development. Neurotoxicology 1987, 8, 395-401.
• 11. BakerE.L. i in.: Occupational lead nephropathy and rend caner. Am. J. Ind. Med. 1980, 1, 138-148.
• 12. Baker E.L. i in.: Occupational lead poisoning in the United States. Clinical and biochemical findings related to blood lead levels. Brit. J. Ind. Med. 1979, 36, 314-322.
• 13. Baker E.L. i in.: The role of occupational lead in the genesis of psychiatric and behavioral disturbances. Acta Psychiatr. Scand. 1983, suppl. 67, 38-48.
• 14. Bauchinger M., M. Schmidt E.: Chromosomenanalysen in Zellkulturen des chinesischen Hamsters nach Application von Bleiacetat. Mut Res. 1972, 14, 95-100.
• 15. Bauchinger i in.: Chromosome analyses of children after ecological lead exposure. Mutation Res. 1977, 56, 75-80.
• 16. Beck B., Obe G.: Effect of lead acetate on human leukocyte chromosomes in vitro. Experientia 1974, 30, 1006-1007.
• 17. Bellinger D. i in.: Longitudal analyses of prenetal and postnatal lead exposure and early cognitive development. N. Eng. J. Med. 1987, 316, 1037-1043.
• 18. Bijlsma J.B., de France G.F.: Cytogenic investigations in volunteers ingesting inorganic lead. Int. Arch. Occup. Environ. Health 1976, 38, 145-148.
• 19. Bishop L., Hill W.J.: A study of the relationship between blood lead levels and occupational air lead levels. The Am Statistitian 1983, 37,471-475.
• 20. Bomschein R.L. i in.: Effects of prenatal lead exposure on infant size and brith. [W:] EPA/EEC Conference on Lead Exposure and Neurobehavioral Effects in Children. Edinburgh 1986, Sept 8-12.
• 21. Bruce W.R., J.A.: The mutagenic activity of 61 agents as determined by the micronucleus. Salmonella and sperm abnormality assays. Can. J. Genet. Cytol. 1979, 21, 319-334.
• 22. Bucket J.P. i in.: Assessment of renal function of workers exposed to inorganic lead, cadmium or marcury vapor. J. Occup. Med. 1980,22,741-749.
• 23. Campara P. i in.: Psychological performance of workers with blood lead concentration below the current threshold limit value. Int. Arch. Occup. Environ. Heath 1984, 53, 233-246.
• 24. Cardenas A. i in.: Markers of early renal changes induced by industrial pollutants. II Application to workers exposed to lead. Br. J.Ind.Med. 1993, 50, 28-36.
• 25. Carlisle J.C., Wade M.J.: Predicting blood lead concentrations from environmental concentrations. Regulatory Toxicol Pharmacol 1992, 16,280-289.
• 26. Chia S.E. i in.: Postural stability of workers exposed to lead. Occup. Environ. Med. 1994, 51,768-771.
• 27. Chia S.E. i in.: Urinary N-acetyl-beta-D-glucosaminidase activity in workers exposed to inorganic lead. Occup. Environ. Med. 1994, 51, 125-129.
• 28. Chislom J.J.: Dose effect relationship for lead in young children: Evidence in children for interactions among lead, zinc, and iron. [W:] Environmental lead. Proceedings on the Second International Symposium on Environmental Lead Research. Cincinnati 1978. New York, Academic Press 1981, s. 1-7.
• 29. Chowdhury A.R. i in.: Effect of lead on human semen. Adv. Contracept. Deliv. Syst. 1986, 2, 208-211.
• 30. Cooper W.C., Gaffey W.R.: Mortality of lead workers. J. Occup. Med. 1975, 17, 100-107.
• 31. Cooper W.C., Ong O., Kheifets L.: Mortality among employees of lead battery plants and lead producing plants 1947-1980. Scand. J. Work Environ. Health 1985, 11, 331-345.
• 32. Cooper W.C., Tabershaw I.R., Nelson K.W. [W:] Evironmental health aspects of lead. C.E.C., Center for Information and Documentation (CID). Luxembourg 1973, s. 517-530.
• 33. Coratelii P. i in.: Enzymuria to detect tubular injury in workers exposed to lead: a 12 month follow-up. Contrib. Nephrol. 1988, 68, 207-211.
• 34. Coscia G.C., Discalci G„ Ponzetti C.: Immunological aspects of occupational lead exposure. Med. Lav. 1987, 78, 360-364.
• 35. Costa M. i in.: Toxic metals produce S-phase Specific cell cycle block. Res. Coomun. Chem. Pathol. Pharmacol. 1982, 38,405-419.
• 36. Coste J. i in.: Lead-exposed workmen and fertility. A cohort study on 354 subjects. Eur. J. Epidemiol. 1991, 7,154-158.
• 37. Cramer K. i in.: Renal ultrastructure, renal function, and parameters of lead toxicity in workers with different period of lead exposure. Br. J. Ind. Med. 1974, 31,113-127.
• 38. Dalpra L. i in.: SCE analysis in children exposed to lead emission from a smelting plant. Mutation Res. 1983, 120, 249-256.
• 39. Dekundt G., Leonard A., Ivanov B.: Chromosomal aberrations observed in male workers professionally exposed to lead. Environ. Physiol, Biochem. 1973, 3, 132-138.
• 40. Dekundt G.Y., Mannel Y., Gerber G.B.: Chromosomal aberrations in workers professionally exposed to lead. J. Toxicol. Environ. Health 1977, 3, 885-891.
• 41. De Silva P.E.: Determination of lead in plasma and studies on its relationship to lead in erythrocytes. Ber. J. Ind. Med. 1981,38, 209-217.
• 42. Dhawan M. i in.: Chelation of lead during co-exposure to ethanol. Biochem. Int. 1989, 19, 1067-1075.
• 43. Dietrych K.N. i in.: Low-level fetal lead exposure effect on neurobehavioral development in early infancy. Pediatrics 1987, 80, 721-730.
• 44. Dingwall-Fordyce I., Lane R.E.: A follow up study of lead workers. Br. J. Ind. Med. 1963, 20, 313-320.
• 45. Discalzi G: Effects of occupationaal to mercury and lead on brainstem auditory evoked potentials. Int. J. Psychophysiol. 1993, 14, 21-25.
• 46. Dolenc i in.: Short report. Low-level lead exposure does not increase the blood pressure in the general population. J. Hypertension. 1993, 11, 589-593.
• 47. Dunkel V.C. i in.: Reproducibility of microbal mutagenicity assays. I Tests with Salmonella typhimurium and Escherichia coli using a standardized protocol. Environ. Mutagen 1984, 6, Suppl. 2, 1-254.
• 48. Dutkiewicz B., Dutkiewicz T., Milkowska G.: The effect of mixed exposure to lead and zincc on ALA level in urine. Int. Arch. Occup. Environ. Health 1979, 42, 341-348.
• 49. Elinder C.G. i in.: Biological monitoring of metals. IPCS, Chemical Safety Monographs, WHO, Geneva 1984.
• 50. Emhart C.B. i in.: Intrauterine exposure to low levels of lead: the status of the neonate. Arch. Environ. Health 1986, 41, 287-291.
• 51. Ewers U., Stiller-Winkler R., Idei H.: Serum immuoglobulin, complement C3, and salivary IgA level in lead workers. Environ. Res. 1982,29, 351-357.
• 52. Flora S.J.S., Fandon S.K.: Effects of combined exposure to lead and ethanol on some biochemical indices in the rat. Biochem. Pharm. 1987, 36,537-541.
• 53. Fomi A., Camiaghi G., Sechi G.C.: Initial occupational exposure to lead. Chromosome and biochemical findings. Arch. Environ. Health. 1976, 31, 73-78.
• 54. Fomi A. i in.: Chromosome and biochemical studies in women occupationally exposed to lead. Arch. Environ. Health 1980, 35, 139-146.
• 55. Frydrych J.: Narażenie na ołów w przemyśle śląskim. Med. Pracy 1993,44, Supl, 1, 115-126.
• 56. Fukunaga M., Kurachi Y., Mizuguchi Y.: Action of some metal ions at yeast chromosomes. Chem. Pharm. Bull. 1982, 30, 3017-3019.
• 57. Fulton M. i in.: Influence of blood lead on the ability and the attainment of children in Edinburgh. Lancet 1987, 30 may, 1221-1226.
• 58. Gartside P.S., Buncher C.R.: Relationship of air lead lead and blood lead for workers at an automobile bettery factory. Int. Arch. Occup. Environ Health 1982, 50, 1-10.
• 59. Garza-Chapa R., Leal-Garza C.H., Molina-Ballesteros G.: Chromosome analysis in subjects exposed professionally to lead contamination. Arch. Invest. Med. 1987, 8, 11-20.
• 60. Gasiorek K., Bauschinger M.: Chromosome changess in human lymphocytes after separate and combined treatment with divalent salts of lead, cadmium and zinc. Environ. Mut. 19981, 3, 513-518.
• 61. GathJ., Thies A.M.\ Chromosome studies in chemical workers. Zentralbl. Arbeitsmed. 1972, 22, 357-362.
• 62. Gerhardsson L. i in.: Mortality and lead exposure. A retrospective cohort study of Swedish smelter workers. Br. J. Ind. Med. 1986,43,707-712.
• 63. Goyer R.: Lead toxicity. From overt to subclinical to subtle health effects. Environ. Health Perspect. 1990, 86, 177-181.
• 64. Goyer R.A.: Mechanisms of lead and cadmium nephrotoxicity. Toxicology Letters 1989,46, 153-162.
• 65. Goyer R.A.: Transplacental transport of lead. Environ. Health Persp. 1990, 89, 101-105.
• 66. Goyer R.A. i in.: Lead induced nephrotoxicity. Kidney calcium as an indicator of tabular injury. [W:]
• 67. Goyer R.A. i in.: Lead induced nephrotoxicity. Kidney calcium as an indicator of tubular injury. [W:] Nephrotoxicity in vitro to in vivo, animals to man. P.H. Bach i E.A. Lock [red.]. New York, Plenum Press 1989, s. 11-20.
• 68. Grandjean P.: Occupational lead exposure in Danmark. Screening with the haematofluorometer. Br. J. Ind. Med. 1979, 36, 52-58.
• 69. Grandjean P., Wulf H.C., Niebuhr E.: Sister chromatid exchange in response to variations and occupational lead exposure. Environ. Res. 1983, 32, 199-204.
• 70. Griffin T.B., Coulston F., Wilis H.: Biological and clinical effects of continuous exposure to airborne particulate lead. Arch. Hig. Toksicol. 1975, 26, 191-206.
• 71. Haeger-Aronsen B., Abdulla M., Fristedt B.I.: Effect of lead on delta-aminolevulinic acid dehydrase activity in red blood cells. Arch. Environ. Health 1971, 23,440-445.
• 72. Hanninen H. i in.: Psychological performance of subjects with low exposure to lead. J. Occup.Med. 1978, 26, 683-689.
• 73. Harlan W.R.: The relationship of blood lead levels to blood pressure in the US population. Environ. Health Perspect. 1988, 78, 9-13.
• 74. Harlan W.R. i in.: Blood lead and blood pressure. Relationship in the adolescent and adult US population. JAMA 1988,253, 530-534.
• 75. Hawk B.A. i in.: Relation of lead and social factors to IQ of low-SES children: a partial replication. Am. J. Ment. Def. 1986,91,178-183.
• 76. Heard M.J., Chamberlain A.C.: Effects of minerals and food on uptake of lead from the gastrointestinal tract in humans. Human. Toxicil. 1982, 1,411-416.
• 77. Hemberg S. i in.: Delta-aminolevulinic acid as a measure of lead exposure. Arch. Eviron. Health 1970, 21, 140-145.
• 78. Hemberg S. i in.: Erythroceyte delta-aminolevulinic acid dehydratase in new lead exposure. Arch. Environ. Health 1972, 21, 140-145.
• 79. Hoffman D.J., Niyogi S.K.: Metal mutagens and carcinogens affect RNA synthesis rates in a distinct manner. Science 1977, 198, 513-514.
• 80. Hogstedt C. i in.: Neurophysiological test results and symptoms among workers with well-defined longterm exposure to lead. Br J. Ind. Med. 1983, 40, 99-105.
• 81. Holness D.L., Nethercott J.R. : Acute lead intoxication in a group of demolition workers. Appl. Ind. Hyg. 1988, 3, 338-341.
• 82. Huang X.P. i in.: Chromosomal aberrations and sister chromatid exchanges in workers exposed to lead. Biomed. Environ. Sci. 1988, 1, 382-387.
• 83. Jakubowski M.: Poziomy biologiczne ołowiu u mieszkańców Polski. Med. Pracy 1993,44, Supl.l ,15-4.
• 84. James H.M., Hilbum M.E., Blair J.A.: Effects of meals amd meal times on uptake of lead from the gastrintestinal tract in humans. Human. Toxicol. 1985, 4,401-407.
• 85. Kharab P., Singh I.: Genotoxic effects of potassium dichromate, sodium arsenrte, cobatt chloride and lead nitrate in diploid yeasts. Mut. Res. 1985,155, 117-120.
• 86. Kimber I. i in.: Influence of chronic low-level exposure to lead on plasma immunoglobulin concentration and cellular immune function in man. Int. Arch. Occup. Eviron. Health 1986, 57, 117-125.
• 87. King E i in.: Industrial lead absorption. Ann. Occup. Hyg. 1979, 22, 213-239.
• 88. Kirkby H., Gyntelberg F.: Blood pressure and other cardiovascular risk factors of long-term exposure to lead. Scand. J Work Environ, Health 1985, 11,1 s-19.
• 89. Kononen D.W.: First-year changes in blood lead and zinc protoporphyrin levels wrthin two groups of occupational lead workers. Am. Ind. Hyg. Assoc. J. 1991, 52,177-182.
• 90. Kumar S., Jain S., Aggarwal C.S. : Encephalopathy due to inorganic lead exposure in an adult. Japn. J. Med. 1987, 26, 253-254.
• 91. Lancrajan I. i in.: Reproductive ability of workmen occupationally exposed to lead. Arch. Environ. Health 1975, 30, 396-401.
• 92. Landis J.R., Flegal K.: A generalized Mantel-Haenszel analysis of the regression of blood pressure on blood lead using NHANES II data. Environ. Health Perspect. 1988, 78, 35-41.
• 93. Landrigan P.J.: Current issues in the epidemiology and toxicology of occupational exposure to lead. Environ. Health Perspect. 1990, 89, 61-66.
• 94. Landsdown R. i in.: The relationship between blood-level concentrations, intelligence, attainment and behaviour in school population: the second study. Int. Arch. Occup. Environ. Health 1986, 57, 225-235.
• 95. Lauwerys R. i in.: Relationship between urinary delta-aminolevulinic acid excretion and the inhibition of red cell delta-aminolevulinate dehydratase by lead. Clinical Toxicology 1974, 7, 383-388.
• 96. Lilis R.: Long-term occupational lead exposure, chronic nephropathy, and renat cancer. A case report. Am. J. Ind. Med. 1981,2,293-102.
• 97. Lilis R. i in.: Hemoglobin, serum iron, and zinc protoporphyrin in leadexposed workers. Environ. Health Perspect. 1978, 25, 97-102.
• 98. Lilis R. i in.: Nephropathy in chronic lead poisoning. Br. J. Ind. Med. 1968, 25,196-202.
• 99. Lilis R. i in.: Renal function impairment in secondary lead smelter workers: correlation with zinc protoporphyrin and blood lead levels. J. Environ. Pathol. Toxicol. 1979, 2,1447-1474.
• 100. Lockith G.: Perspectives on lead toxicity. Clin. Biochem. 1993, 26, 371-381.
• 101. Lumens M. i in.: The impact of hygienic behavior and working methods on the uptake of lead and chromium. Appl. Occup. Environ. Hyg. 1994, 9, 53-56.
• 102. Maeki-Pakkanen J., Sorsa M„ Vainio H.: Chromosome aberrations and sister chromatid exchange in leadexposed workers. Heriditas 1981, 94, 269-275.
• 103. Maheswaran R., Singh Gill J., Beevers D.G.: Blood pressure and industrial lead exposure. Am. J. Epidemiology 1993, 137, 645-653.
• 104. Malcolm D., Barnett H.A.R.: A mortality study of lead workers. Br. J. Ind. Med. 1982, 39, 404-410.
• 105. Maniere P., Hanninen H., Hernberg S.: Subclinical neurotoxic lead effects. Two-year follow-up studies with psychological test methods. Neurobehav. Toxicol. Teratol. 1982, 4, 725-727.
• 106. Marcus A.H.: Multicompartment kinetic model for lead: part 1. Bone diffusion models for long-term retention. Environ. Res. 1985, 36, 441-458.
• 107. Marcus A.H.: Multicompartment kinetic models for lead : part III. Lead in blood, plasma and erythrocytes. Environ. Res. 1985, 36, 473-489.
• 108. Marek K.: Zagrożenie ołowiem w przemyśle polskim. Med. Pracy 1993, 44, Supl. 1, 35-42.
• 109. Marino P.E. i in.: Acute lead poisoning in construction workers. The failure of current protective standards. Arch. Environ. Health 1989,44,140-145.
• 110. Matsumoto T. i in.: Relations between lead exposure and peripheral-neuromuscular functions of lead-exposed workers - results of tapping test. Environ. Res. 1993, 61, 299-307.
• 111. Matte T.D. i in.: Lead exposure among lead-acid battery workers in Jamaica. A. J. Ind. Med. 1989, 16, 167- 177.
• 112. McMichael A.J. i in.: The Port Pirie cohort study. Maternal blood lead and pregnancy outcome. J. Epidemiol. Community 1986,40, 18-25.
• 113. Meyer B.R. in.: Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am. J. Med. 1984,76, 989-998.
• 114. Monographs on the evaluation of carcinogenic risk to humans. Supplement 7. Lead and lead compounds. Lead and inorganic lead compounds (Group 2B). Organoled compounds (Group 3). Lyon, IARC 1987.
• 115. Muijser H. i in.: Lead exposure during demolition of a steel structure coated with lead-based paints. II. Reversible changes in the conduction velocity of the motor nerves in transiently exposed workers. Scand. J. Work. Environ. Health 1987, 13, 56-61.
• 116. Murphy M.J. i in.: Past pregnancy outcomes among women living in the vicinity of lead smelter in Kosovo. Yugoslavia. Am. J. Public. Health 1990, 80, 33-35.
• 117. Nedelman H.J. i in.: The long-term effects of exposure to low doses of lead in childhood: an 11 year follow- up raport. N. Engl. J. Med. 1979, 322, 83-88.
• 118. Neri L.C., Hewitt D., Or ser B.: Blood lead and blood pressure: analysis of cross-sectional and longitudal data from Canada. Environ. Health Pesrpectives 1988, 78,123-126.
• 119. Nestman E.R. i in.: Detection of the mutagenic activity of lead chromate using a battery of microbal tests. Mut. Res. 1979 66, 357-365.
• 120. Nordenson I .i in.: Occupational and environmental risks in and around a smelter in northern Sweden. IV. Chromosomal aberrations in workers exposed to lead. Heredirtas 1978, 88, 263-267.
• 121. Nordstrom S., Beckman L., Nordenson I.: Occupational and environmental risks in and around a smelter in northern Sweden. V. Spontaneous abortion among female employees and decreased birth weight of their offspring. Hereditas 1979, 90, 291-296.
• 122. Nuyts G.D., Elseviers M.M., De Broe M.E.: Healthy worker effect in a cross-sectional study of lead workers. J. Occup. Med. 1993, 35, 387-391.
• 123. O'Riordan M.L., Evans H.J.: Absence of significant chromosome damage in males occupationally exposed to lead. Nature 1974, 247, 50-53.
• 124. PaglicuaA. i in.: Lead poisoning. Clinical, biochemical, and hematological aspects of a recent outbreak. J. Clin. Path 1990, 43, 277-281.
• 125. Parkinson D.K. i in.: Occupational lead exposure and blood pressure. Br. J. Ind. Med. 1987,44,744-748.
• 126. Pasternak G. in.: Cross-sectional neurotoxicology study of lead-exposed cohort. Clin. Toxicol. 1989, 27, 37-51.
• 127. Pinto de Almeida A.R. i in.: Renal dysfunction in Brazilian lead workers. Am. J. Nephrol. 1987,7,455-458.
• 128. Pirkle J.L. i in.: The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am. J. Epidemiol. 1985, 121, 246-258.
• 129. Pocock S.J. i in.: Blood lead and blood pressure in middle aged men. [W]: International Conference on Heavy Metals in the Environment. T.D. Lekkas. [red.] T.l. Athens, Edinburgh. U.K CEP Consultants, Ltd, s. 303-305.
• 130. Preventing lead poisoning in young children. A statement by Centers for Disase Control. U.S. Department of Health and Human Services 1991, October.
• 131. Queiroz M.L.S. i in.: Immunoglobulin levels and cellular immune function in lead exposed workers. Immuopharm Immunotox. 1994,16,115-128 ()
• 132. Rabinowitz M.B., Wetherill G.W., Kopple J.D.: Kinetic analysis of lead metabolism in healthy humans. J. Clin. Invest. 1976, 58, 260-270.
• 133. Ramirez-Cervantes B. i in.: Health assessment of employes with different body burdens of lead. J. Occup. Med. 1978, 20, 610-617.
• 134. Raport Komisji Toksykologicznej Rady Sanitamo-Epidemiologicznej. Med. Pracy 1993,44, 5-13.
• 135. Recommeded health-based limits in cccupational exposure to heavy metals. Geneva, WHO, Technical Report Series 1980.
• 136. Robison S.H., Cantoni O., Costa M.: Analysis of metal-induced DNA lesions and DNA-repair replication in mammalian cells. Mut. Res. 1984,131, 173-181.
• 137. Rocznik statystyczny. Warszawa, GUS. 1993.
• 138. Roels H.A., Lauwerys R.: Evaluation of dose-effect and dose-response relationships for lead exposure in different Belgian population groups (fetus, child, adult men and women). Trace Elements in Medicine 1987,4, 80-87.
• 139. Roels H.A. i in.: The influence of sex and of chelation therapy on erythrocyte protoporphyrin and urinary delta-aminolevulinic acid in lead-exposed workers. J. Occup. Med. 1979,21, 527-539.
• 140. Rosen I. i in.: Neurophysiological effects of lead exposure. Scand. J. Work Environ. Health 1983, 9, 431- 441.
• 141. Rosenkranz H.S., Poirier L.A.: Evaluation of the mutagenicity and DNA-modyfiyng activity of carcinogens and noncarcinogens in microbal systems. J.Natl.Cancer Inst. 1979, 11,873-892.
• 142. Ryan CM. i in.: Low level lead exposure and neuropsychological functioning in blue-collar males. Int. J. Neurosci 1987, 36, 29-39.
• 143. Sarto F., Stella M., Acqua A.: Cytogenic studies in 20 workers occupationally exposed to lead. Med. Lavoro 1978, 69, 172-180.
• 144. Sax N.I.: Dangerous properties of industrial materials. 6th ed. New York, Van Nostrand Reinhold Company 1987.
• 145. Schmidt E. i in.: Cytogenic action of lead in human peripheral lymphocytes in vivo and in vitro. Mut. Res. 1972,16,420-406.
• 146. Schroeder S.R. i in.: Separating the effects of lead and social factors on IQ. Environ. Res. 1985, 38,144- 154.
• 147. Schütz A. i in.: Kinetics of lead in blood after the end of occupational exposure. Scand. J. Work Environ. Health 1987, 13, 221-231.
• 148. Schwanitz G., Zlenhert G., Gebhard E.: Chromosome damage after occupational exposure to lead. Deutsche Med. Wochenschr. 1970, 95,1636-1641.
• 149. Schwanitz G. i in.: Chromosome investigations in subjects with occupational lead exposure. Deutsche Med. Wochenschr. 1975, 100, 1007-1011.
• 150. Schwartz J.: Lead, blood pressure, and cardiovascular disease in men and women. Environ. Health Persp. 1991,91,71-75.
• 151. Schwartz J.: The relationship between blood lead and blood pressure in the NHANES II survey. Environ. Health Perspect. 1988,78,15-22.
• 152. Selevan S.G. i in.: Mortality of lead smelter workers. Am. J. Epidemiol. 1985, 122, 673-683.
• 153. Seppalainen A.M. i in.: Early neurotoxic effects of occupational lead exposure. A prospective study. Neurotoxicology 1983,4,181-192.
• 154. Silbergeld E.K.: Toward the twenty-first century: lessons from lead and lessons yet to learn. Environ. Health Perspect. 1990, 86,191-196.
• 155. Silbergeld E.K, Schwartz J., Mahffey K.: Lead and osteoporosis. Mobilisation of lead from bone in postmenopausal women. Environmental Res. 1988, 47, 79-94.
• 156. Simmon V.F.: In vitro assays for recombinogenic activity of chemical carcinogens and related compounds with Sachharomyces cerevisiae D3. J. Nat. Cancer Inst. 1979, 62,901-909.
• 157. Simmon V.F.: In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium. J. Nat. Cancer Inst. 1979, 62, 893-899.
• 158. Staessen J.A., Lauwerys R.R., Bulpitt C.J.: Is a positive association between lead and exposure and blood pressure supported by animal experiments? Current Opinion in Neprhrology and Hypertension 1994, 3, 257-263.
• 159. Staessen J.A. i in.: Impairment of renal function with increasing blood lead concentrations in the general population. New England J. Med. 1992, 327,151-156.
• 160. Stollery B.T. i in.: Cognitive functioning of lead workers. Br. J. Ind. Med. 1989,46, 698-707.
• 161. Tola S. i in.: Parameters indicative of absorption and biological effect in new lead exposure. A prospective study. Br. J. Ind. Med. 1973, 30,134-141.
• 162. Tomokuni K., Ichiba M., Fujishiro K.: Interrelation between urinary delta-aminolevulinic acid (ALA), serum ALA, and blood lead in workers exposed to lead. Industrial Health 1993, 31, 51-57.
• 163. Toxicological profile for lead. U.S. Department of Health and Human Services. Public Health Service. Agency for Toxic Substances and Disease Registry 1993.
• 164. Tsuchiya K.: Lead. W: Handbook of the toxicology of metals. T II. L. Friberg, G.F Nordberg, V.B. Vouk [red.]. Elsevier, Amsterdam 1986, 299-353.
• 165. Valucikas J.A. i in.: Behavioral indicators of lead neurotoxicity. Results of a clinical field survey. Int. Arch. Occup. Environ. Health 1978, 41, 217-236.
• 166. Verschoor M. i in.: Influence of occupational low-level lead exposure on renal parameters. Am. J. Ind. Med. 1987,12, 341-351.
• 167. Wada O. i in.: The diagnosis of different degrees of lead absorption in special references to choice and evaluation of various parameters indicative of an increased lead absorption. Ind. Health 1973, 11, 55-67.
• 168. Weast R.G. [red.]: Handbook of chemistry and physics. Wyd. 55. Cleveland, Chemical Rubber Company 1974.
• 169. Wedeen R.P., Mallik D.K, Batuman V.: Detection and treatment of occupational lead nephropathy. Arch. Intern. Med. 1979, 139, 53-57.
• 170. Weiss S.T. i in.: The relationship of blood lead to systolic blood pressure in a longitudal study of policemen. Environ. Health Perspect. 1988,78, 53-56.
• 171. Williamson A.M., Teo R.K.C.: Neurobehavioral effects of occupational exposure to lead. Br. J. Ind. Med. 1986.43, 374-380.'
• 172. Winder C.: Reproductive effects of occupational exposures to lead. Policy considerations. Neurotoxicology 1987, 8, 411-419.
• 173. Winneke G. i in.: Results from the European multicenter study on lead neurotoxicity in children: implications for risk assessment. Neurotoxicity and Teratology 1990, 12, 553-559.
• 174. Wittmers L.E. i in.: Lead in bone. IV. Distribution of lead in the human skeleton. Arch. Environ. Health 1988.43, 381-391.
• 175. Yule W. in.: The relationship between blood lead concentrations, intelligence, and attainment in a school population; a pilot study. Dev. Med. Child. Neurol. 1981, 23, 567-76.
• 176. Zanieczyszczenie powietrza w Polsce w 1993 roku. Biblioteka Monitoringu Środowiska. Warszawa 1994, PIOŚ, PIS.
• 177. Zimmerman-Tansella C. i in.: Psychological and physical complaints of subjects with low exposure to lead. Hum. Toxicol. 1983,2, 615-623.